GETI.B

213.1

0%↓

CAMX

606.5

-0.25%↓

BIOAB

321.4

+0.82%↑

EKTA.B

56.05

-0.09%↓

VITR

137.7

-0.22%↓

GETI.B

213.1

0%↓

CAMX

606.5

-0.25%↓

BIOAB

321.4

+0.82%↑

EKTA.B

56.05

-0.09%↓

VITR

137.7

-0.22%↓

GETI.B

213.1

0%↓

CAMX

606.5

-0.25%↓

BIOAB

321.4

+0.82%↑

EKTA.B

56.05

-0.09%↓

VITR

137.7

-0.22%↓

GETI.B

213.1

0%↓

CAMX

606.5

-0.25%↓

BIOAB

321.4

+0.82%↑

EKTA.B

56.05

-0.09%↓

VITR

137.7

-0.22%↓

GETI.B

213.1

0%↓

CAMX

606.5

-0.25%↓

BIOAB

321.4

+0.82%↑

EKTA.B

56.05

-0.09%↓

VITR

137.7

-0.22%↓

Home・Akciju saraksts・Vivesto AB

Vivesto AB

Atvērts

0.22

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.22

Max

0.22

Galvenie mērījumi
By Trading Economics
Ienākumi	2.3M -7.2M
EPS	-0.013
Darbinieki	4
EBITDA	-7.1M

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-5.5M 73M
Iepriekšējā atvēršanas cena	0.22
Iepriekšējā slēgšanas cena	0.22

Vivesto AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 24. dec. 21:41 UTC

Iegādes, apvienošanās, pārņemšana

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

2025. g. 24. dec. 14:57 UTC

Iegādes, apvienošanās, pārņemšana

Accenture to Acquire Cabel Industry from Fibonacci Group

2025. g. 24. dec. 12:48 UTC

Galvenie tirgus virzītāji

Iegādes, apvienošanās, pārņemšana

Repare Therapeutics Shares Rise on $30 Million Asset Deal With Gilead

2025. g. 24. dec. 12:21 UTC

Galvenie tirgus virzītāji

Nike Shares Tick Up After Apple CEO Tim Cook Buys $2.9 Million of Its Stock

2025. g. 24. dec. 22:22 UTC

Iegādes, apvienošanās, pārņemšana

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

2025. g. 24. dec. 21:26 UTC

Iegādes, apvienošanās, pārņemšana

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

2025. g. 24. dec. 19:35 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 24. dec. 19:35 UTC

Tirgus saruna

Treasury Yields Decline Ahead of Christmas -- Market Talk

2025. g. 24. dec. 19:09 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Global Equities Roundup: Market Talk

2025. g. 24. dec. 19:09 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

2025. g. 24. dec. 19:06 UTC

Tirgus saruna

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

2025. g. 24. dec. 19:03 UTC

Tirgus saruna

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

2025. g. 24. dec. 17:20 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2025. g. 24. dec. 17:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 24. dec. 17:08 UTC

Iegādes, apvienošanās, pārņemšana

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

2025. g. 24. dec. 16:53 UTC

Iegādes, apvienošanās, pārņemšana

Nike Climb Boosts Dow, S&P 500 -- WSJ

2025. g. 24. dec. 16:31 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

2025. g. 24. dec. 16:28 UTC

Iegādes, apvienošanās, pārņemšana

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

2025. g. 24. dec. 16:17 UTC

Tirgus saruna

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

2025. g. 24. dec. 15:33 UTC

Iegādes, apvienošanās, pārņemšana

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

2025. g. 24. dec. 15:30 UTC

Iegādes, apvienošanās, pārņemšana

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025. g. 24. dec. 15:19 UTC

Iegādes, apvienošanās, pārņemšana

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025. g. 24. dec. 14:49 UTC

Iegādes, apvienošanās, pārņemšana

Mexico's Ollamani Sells Stake in Azteca Stadium

2025. g. 24. dec. 14:19 UTC

Tirgus saruna

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

2025. g. 24. dec. 14:08 UTC

Iegādes, apvienošanās, pārņemšana

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025. g. 24. dec. 14:06 UTC

Tirgus saruna

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

2025. g. 24. dec. 13:24 UTC

Tirgus saruna

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

2025. g. 24. dec. 12:59 UTC

Iegādes, apvienošanās, pārņemšana

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

2025. g. 24. dec. 12:51 UTC

Iegādes, apvienošanās, pārņemšana

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

2025. g. 24. dec. 12:38 UTC

Iegādes, apvienošanās, pārņemšana

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Vivesto AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.